SIGN UP
LOG IN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·07/29/2025 12:07:53
Listen to the news
Gainers
- Durect (NASDAQ:DRRX) shares moved upwards by 270.9% to $2.05 during Tuesday's pre-market session. The company's market cap stands at $17.1 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 150.97% to $1.86. The company's market cap stands at $1.5 million.
- Calidi Biotherapeutics (AMEX:CLDI) stock rose 50.14% to $0.83. The market value of their outstanding shares is at $18.9 million.
- Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 42.43% to $2.92. The company's market cap stands at $1.9 million.
- Sarepta Therapeutics (NASDAQ:SRPT) shares rose 37.92% to $19.12. The market value of their outstanding shares is at $1.3 billion.
- GeneDx Holdings (NASDAQ:WGS) stock rose 27.54% to $108.3. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q2 earnings report came out today.
Losers
- AIM ImmunoTech (AMEX:AIM) stock decreased by 39.6% to $4.35 during Tuesday's pre-market session. The company's market cap stands at $5.5 million.
- Ekso Bionics Holdings (NASDAQ:EKSO) stock fell 24.51% to $3.42. The company's market cap stands at $10.7 million. As per the news, the Q2 earnings report came out yesterday.
- Novo Nordisk (NYSE:NVO) stock fell 20.96% to $54.54. The market value of their outstanding shares is at $306.5 billion.
- Fulcrum Therapeutics (NASDAQ:FULC) stock decreased by 15.5% to $6.6. The market value of their outstanding shares is at $421.5 million. As per the news, the Q2 earnings report came out today.
- NeoGenomics (NASDAQ:NEO) stock fell 15.1% to $5.49. The market value of their outstanding shares is at $831.3 million. As per the press release, Q2 earnings came out today.
- Catheter Precision (AMEX:VTAK) stock decreased by 14.15% to $0.19. The company's market cap stands at $2.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.